SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Carlos Andrade, João Beato, Ana Monteiro, Andreia Costa, Susana Penas, Joana Guimarães, Fernando Falcão Reis, Carolina Garrett, Spectral-Domain Optical Coherence Tomography as a Potential Biomarker in Huntington's Disease, Movement Disorders, 2016, 31, 2
  2. 2
    José Francisco Rocha, Ana Santos, Amílcar Falcão, Nelson Lopes, Teresa Nunes, Roberto Pinto, Patrício Soares-da-Silva, Effect of moderate liver impairment on the pharmacokinetics of opicapone, European Journal of Clinical Pharmacology, 2014, 70, 3, 279

    CrossRef

  3. 3
    Anja Mähler, Jochen Steiniger, Matthias Endres, Friedemann Paul, Michael Boschmann, Sarah Doss, Increased Catabolic State in Spinocerebellar Ataxia Type 1 Patients, The Cerebellum, 2014, 13, 4, 440

    CrossRef

  4. 4
    László E. Kiss, Patrício Soares-da-Silva, Medicinal Chemistry of CatecholO-Methyltransferase (COMT) Inhibitors and Their Therapeutic Utility, Journal of Medicinal Chemistry, 2014, 57, 21, 8692

    CrossRef

  5. 5
    Linda Salem, Nadine Saleh, Katia Youssov, Audrey Olivier, Perrine Charles, Clarisse Scherer, Christophe Verny, Anne-Catherine Bachoud-Lévi, Patrick Maison, The most appropriate primary outcomes to design clinical trials on Huntington's disease: meta-analyses of cohort studies and randomized placebo-controlled trials, Fundamental & Clinical Pharmacology, 2014, 28, 6
  6. 6
    Jeffery D. Long, Jane S. Paulsen, Karen Marder, Ying Zhang, Ji-In Kim, James A. Mills, Tracking motor impairments in the progression of Huntington's disease, Movement Disorders, 2014, 29, 3
  7. 7
    Chris Tang, Andrew Feigin, Monitoring Huntington’s disease progression through preclinical and early stages, Neurodegenerative Disease Management, 2012, 2, 4, 421

    CrossRef